$ACAD Recent Headlines This tiny mutual fund is no. 1 for

New Post Public Reply Private Reply Replies (0) Message Board

Feb 26, 2014 at 10:15 AM

$ACAD Recent Headlines

This tiny mutual fund is no. 1 for 2013 7:33 a.m. Jan. 7, 2014 - Suzanne McGee
Despite Fed concerns, technicals support bull case 1:16 p.m. Sept. 17, 2013 - Michael Ashbaugh
Despite Fed concerns, technicals support bull case 12:02 p.m. Sept. 17, 2013 - Michael Ashbaugh
A bull market not ready to be put to rest 11:14 a.m. Sept. 5, 2013 - The Trading Deck
Charting the S&P 500’s break to all-time highs 11:47 a.m. Aug. 6, 2013 - Michael Ashbaugh
Longer-term technical risk points higher 11:32 a.m. Aug. 6, 2013 - Michael Ashbaugh
7 gut checks before the stock market's opening bell 5:56 a.m. July 30, 2013 - Shawn Langlois
Charting a strong third-quarter start 11:23 a.m. July 16, 2013 - Michael Ashbaugh
Charting a strong third-quarter start 11:17 a.m. July 16, 2013 - Michael Ashbaugh
Looking for the choicest opportunity 12:37 p.m. June 11, 2013 - The Trading Deck
Declines often spell opportunity 1:11 p.m. June 6, 2013 - The Trading Deck
Don't fight the tape 10:27 a.m. May 28, 2013 - The Trading Deck
Charting the S&P’s uptrend, and its next hurdle 10:55 a.m. April 23, 2013 - Michael Ashbaugh
Charting the S&P’s uptrend, and its next hurdle 10:25 a.m. April 23, 2013 - Michael Ashbaugh
3 longs and 3 shorts to watch 1:33 p.m. April 17, 2013 - The Trading Deck
Dow, S&P pull in from record highs 10:15 a.m. April 12, 2013 - Michael Ashbaugh
S&P 500 chips away at all-time highs 11:01 a.m. April 9, 2013 - Michael Ashbaugh
S&P 500 chips away at all-time highs 10:50 a.m. April 9, 2013 - Michael Ashbaugh
S&P 500 vies for record closing high 11:19 a.m. March 28, 2013 - Michael Ashbaugh
Acadia Pharma up 10% in premarket 9:17 a.m. Dec. 12, 2012 - Steve Gelsi

ACADIA Pharmaceuticals (ACAD) Jumps: Stock Rises 17.3% - Tale of the Tape 9:18 a.m. Feb. 24, 2014 - Zacks.com
Watch Out: Barbarians At The Gate For ACADIA Pharmaceuticals (ACAD) 11:19 a.m. Feb. 21, 2014 - TheStreet.com
Baker Brothers' Holding Cerus Flying Under The Radar With Catalyst Upcoming 8:31 a.m. Feb. 11, 2014 - Seeking Alpha
Commit To Purchase Acadia Pharmaceuticals At $15, Earn 17.9% Annualized Using Options 12:00 p.m. Feb. 5, 2014 - TheStreet.com
Cramer's Lightning Round - Archer Daniels Midland Is Much Ado About Nothing (1/30/14) 6:22 a.m. Jan. 31, 2014 - Seeking Alpha
'Mad Money' Lightning Round: Don't Bet on Boyd Gaming 6:00 a.m. Jan. 31, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Social, Mobile, Cloud Are Buys 8:19 p.m. Jan. 30, 2014 - TheStreet.com
Cramer's Lightning Round - Agilent Is Sensational (1/28/14) 5:16 a.m. Jan. 29, 2014 - Seeking Alpha
Is The Healthcare Sector Pulling Back Or Crashing? 5:40 a.m. Jan. 28, 2014 - Seeking Alpha
Notes From One-On-One Meetings During San Fran Biotech Week - Day 1 9:05 a.m. Jan. 23, 2014 - Seeking Alpha
Acadia slides as SA article paints grim picture 12:39 p.m. Jan. 7, 2014 - Seeking Alpha
Healthcare Stocks To Avoid This Year 10:08 a.m. Jan. 7, 2014 - Seeking Alpha
4 Stocks That Could See Significant Gains In 2014 2:35 p.m. Jan. 6, 2014 - Seeking Alpha
Acadia Pharmaceuticals: 3 Different Insiders Have Sold Shares During The Last 30 Days 11:52 a.m. Jan. 6, 2014 - Seeking Alpha
A Tiny-Stock Fund Is No. 1 for 2013 4:28 p.m. Jan. 5, 2014 - WSJ.com
Top Stocks Of 2013 Run Gamut: Solar, Drugs, Tech, TV 5:59 p.m. Jan. 2, 2014 - Investors Business Daily
Biotech 2013 By The Numbers: A Blockbuster Year 9:13 a.m. Jan. 1, 2014 - TheStreet.com
Taking A Look At A Few Of The Top Performers Of 2013 12:27 p.m. Dec. 30, 2013 - Seeking Alpha
The Billion-Dollar Biotech Club: Speculation Trumped Risk 9:19 a.m. Dec. 30, 2013 - TheStreet.com
Acadia: The Best Hope For Parkinson's Psychosis Sufferers 4:21 p.m. Dec. 27, 2013 - Seeking Alpha

ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2013 Financial Results on February 27, 2014 9:01 a.m. Feb. 20, 2014 - BusinessWire - BZX
Biotech Industry Stock Update: Cell Therapeutics, Sarepta Therapeutics, ACADIA Pharma, and Medivation 8:00 a.m. Jan. 2, 2014 - PR Newswire
Addition to Indices, and Stock Price Movements - Research Report on ACADIA Pharmaceuticals, InterMune, Tandem Diabetes Care, Nektar Therapeutics and Greatbatch 8:00 a.m. Dec. 25, 2013 - PR Newswire
Breakfast Technical Briefing: Sarepta Therapeutics, ACADIA Pharma, Cell Therapeutics, and Medivation 11:23 a.m. Dec. 6, 2013 - PR Newswire
Proposed M&A's, Conference Schedules, Health Awareness Programs, Prestigious Recognitions and FDA Designations - Research Report on Health Management, Acadia, Health Net, NuVasive and Portola 8:00 a.m. Nov. 29, 2013 - PR Newswire
ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences 9:00 a.m. Nov. 26, 2013 - BusinessWire
Disaster Relief Contributions, New Medical Trials, Clinical Results and Employee Incentives - Research Report on UnitedHealth Group, ACADIA, USANA, Portola and Horizon Pharma 8:00 a.m. Nov. 21, 2013 - PR Newswire
Earnings, Trend Analysis: The Dow Chemical, Turquoise Hill Resources, ACADIA Pharmaceuticals, E Commerce China Dangdang, Yum! Brands 9:35 a.m. Nov. 15, 2013 - PR Newswire
ACADIA Pharmaceuticals Announces Initiation of Phase II Trial with Pimavanserin for Alzheimer's Disease Psychosis 9:00 a.m. Nov. 14, 2013 - BusinessWire
Financial Results, Conference Presentations, Stock Price Update, and Warrant Exercises - Research Report on Halozyme Therapeutics, Oxygen Biotherapeutics, ACADIA, MannKind, and ViroPharma 8:00 a.m. Nov. 13, 2013 - PR Newswire
Morning Research: Medivation Inc., ACADIA Pharma Inc., Sarepta Therapeutics Inc., and Cell Therapeutics Inc. 8:00 a.m. Nov. 11, 2013 - PR Newswire
ACAD, CRTX, MACK and NVAX added to NASDAQ Healthcare Stock Watch List at EPR 9:29 a.m. Nov. 7, 2013 - ACCESSWIRE
ACADIA Pharmaceuticals Reports Third Quarter 2013 Financial Results 4:01 p.m. Nov. 6, 2013 - BusinessWire
Clinical Trial Data, New Publications, Promotions, Financial Results and FDA Acknowledgements - Research Report on Gilead, Amgen, ACADIA Pharmaceuticals, ViroPharma, and MannKind 8:00 a.m. Nov. 6, 2013 - PR Newswire
ACADIA Pharmaceuticals Announces Publication in The Lancet of Pivotal Phase III Parkinson's Disease Psychosis Trial with Pimavanserin 7:40 p.m. Oct. 31, 2013 - BusinessWire
Under The Radar Big Pharma Partnership Opportunity for Zalicus,Targacept and ACADIA 4:17 a.m. Oct. 31, 2013 - ACCESSWIRE
ACADIA Pharmaceuticals to Announce Third Quarter 2013 Financial Results on November 6, 2013 8:00 a.m. Oct. 30, 2013 - BusinessWire
Financial Results & Release Schedules, Stock Performance Update, and New Clinical Trials - Research Report on Amgen, Boston Scientific, ACADIA Pharmaceuticals, Seattle Genetics, and Volcano 8:00 a.m. Oct. 29, 2013 - PR Newswire
Pre-Market Review: ACADIA Pharma Inc., Cell Therapeutics Inc., Sarepta Therapeutics Inc., and Medivation Inc. 8:05 a.m. Oct. 21, 2013 - PR Newswire
Critical Alerts For SunPower, Starbucks, ACADIA Pharmaceuticals, Opko Health, and Cytokinetics Released By InvestorsObserver 8:31 a.m. Oct. 16, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tactical Comm Market: $19.39B by 2031 Amid 8.1% CAGR

Riding the Tactical Communication Wave Alright, here’s something to chew on over your morning coffee. The tactical communication market is projected to balloon from USD 13.14 billion in 2026 to a whopping USD 19.39 billion by 2031. That’s an 8.1% CAGR if you’re keeping track—no small peanuts. So what's driving this surge? It’s all about security, modernization,...

ELEGOO Slashes Prices up to 54% for 2026 Holiday Deals

ELEGOO's 2026 Holiday Strategy: Deep Discounts Welcome to the world of sharp deals and crafty creations as ELEGOO kicks off its Black Friday and Cyber Monday extravaganza. This time, they're slashing prices by up to 54% on their impressive lineup of 3D printers and captivating accessories. Yeah, it's that time of year when wallets might take a hit, but for a good reason....

One Stop Swap eyes school fundraising for growth

Transforming Fundraising with a Marketplace Twist Sometimes the real treasures are not tucked in textbooks but found in cluttered closets and basements. Enter One Stop Swap with a big idea—they're cooking up a fundraising strategy for schools that could shake things up by helping families sell their unused stuff. It's got that grassroots vibe with the potential to carve...

Stora Enso's Major Cross-Border Demerger Plan Unfolds

A Grand Meeting with Serious Stakes The Board at Stora Enso Oyj is calling for an Extraordinary General Meeting (EGM) to tackle something massive—a cross-border partial demerger. Scheduled for December 15, 2026, this big pow-wow will take place in Helsinki, Finland. There’s a boatload of logistics in play, not least because it’s intended to split off their Swedish...

PRG Projects' London Studio Elevates Live Entertainment

A New Stage for Creativity in London When the curtain rises on a fresh idea, it's often the unknowns that make or break a production. Now, with PRG Projects unveiling their spanking new Project Studio in London, the tech and creative worlds might just bridge their gap tighter than a stage curtain before showtime. London Welcomes PRG's Innovative Hub This isn't just...

Ceva and Mobilint's New REGULUS: A Game Changer?

A Big Leap for Physical AI Can't pretend I saw this coming—Ceva's making waves with Mobilint's new REGULUS edge AI SoC, aiming to flip the script on how we think about physical AI devices. This combo of Ceva's NeuPro NPU and SensPro AI DSP is more than just tech talk; it's a gutsy move that shows us edge devices might be the hunting ground for AI innovation. Sensors and...

Gildan Faces Class Action Deadline Over Fraud Claims

Gildan's Legal Storm: Fraud Allegations When news hits about a big player like Gildan Activewear (NYSE: GIL) facing a class-action lawsuit, it's like a thunderstorm for investors who traded their stocks between February 19, 2025, and June 15, 2026. This lawsuit alleges what we some might call classic financial engineering—channel stuffing to be precise—that’s got...

Choice Hotels Hits Milestones and Faces Market Scrutiny

Another Quarter Under the Belt Just when you think the hospitality industry's running out of steam, Choice Hotels International decides to shake things up. Reporting their third quarter 2026 results, the big picture here demands an attentive eye from investors. In the turbulent world of lodging franchises, NYSE:CHH is making waves, and I mean literal waves, as they surf...

Allegiant Overhauls Service with UNLV Training

Allegiant Airlines and UNLV: A Unique Collaboration The world of airline customer service is about to get a shakeup, thanks to a new collaboration between Allegiant Airlines and the University of Nevada, Las Vegas' renowned William F. Harrah College of Hospitality. It's a partnership that aims to bring a new level of service to the skies, guided by some of the best minds...

Atrium's Heart Therapies: ATR 1072's Promising Data

Atrium Therapeutics Strikes a Chord with New Data Tuning into the heartbeats of breakthrough developments, Atrium Therapeutics dropped some fresh, nonclinical insights about their latest contender, ATR 1072. This wasn't just any ordinary announcement; it's like when the market hears whispers of a Fed rate adjustment. The venue? The American Heart Association's 2026...